232 related articles for article (PubMed ID: 35082654)
1. A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy.
Minami K; Egawa M; Kajita K; Murao F; Mitamura Y
Case Rep Ophthalmol; 2021; 12(3):952-960. PubMed ID: 35082654
[TBL] [Abstract][Full Text] [Related]
2. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
Obata S; Saishin Y; Teramura K; Ohji M
Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Nivolumab-Induced Vogt-Koyanagi-Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy.
Nagai R; Yamamoto A; Yoshida A; Mikawa A
Case Rep Ophthalmol Med; 2023; 2023():9565205. PubMed ID: 36818144
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
5. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
[TBL] [Abstract][Full Text] [Related]
6. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
Madoe A; Schauwvlieghe PP; Jacob J
Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
[TBL] [Abstract][Full Text] [Related]
7. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
[TBL] [Abstract][Full Text] [Related]
8. [Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma].
Mihailovic N; Dyballa J; Herz S; Fluck M; Alnawaiseh M; Merté RL; Eter N
Ophthalmologe; 2020 May; 117(5):467-471. PubMed ID: 31489479
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review.
Yilmaz Tugan B; Ozkan B; Sonmez O
Semin Ophthalmol; 2021 Nov; 36(8):794-799. PubMed ID: 33780309
[No Abstract] [Full Text] [Related]
10. En Face Optical Coherence Tomography Imaging of the Choroid in a Case with Central Serous Chorioretinopathy during the Course of Vogt-Koyanagi-Harada Disease: A Case Report.
Komuku Y; Iwahashi C; Yano S; Tanaka C; Nakagawa T; Gomi F
Case Rep Ophthalmol; 2015; 6(3):488-94. PubMed ID: 26955354
[TBL] [Abstract][Full Text] [Related]
11. NIVOLUMAB-INDUCED HARADA-LIKE UVEITIS WITH BACILLARY DETACHMENT MIMICKING CHOROIDAL METASTASIS.
Ng CC; Ng JC; Johnson RN; McDonald HR; Agarwal A
Retin Cases Brief Rep; 2023 May; 17(3):233-238. PubMed ID: 34027908
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Vogt–Koyanagi–Harada disease with sensorineural hearing loss and choroidal thickening.
Ishibazawa A; Kinouchi R; Minami Y; Katada A; Yoshida A
Int Ophthalmol; 2014 Jun; 34(3):679-84. PubMed ID: 24022645
[TBL] [Abstract][Full Text] [Related]
13. Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis.
Dogan B; Erol MK; Cengiz A
Springerplus; 2016; 5():603. PubMed ID: 27247899
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Park HS; Nam KY; Kim JY
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
[TBL] [Abstract][Full Text] [Related]
15. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.
Fujimura T; Kambayashi Y; Tanita K; Sato Y; Hidaka T; Otsuka A; Tanaka H; Furudate S; Hashimoto A; Aiba S
J Dermatol; 2018 Jun; 45(6):735-737. PubMed ID: 29488243
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum and management options in Vogt-Koyanagi-Harada disease.
Lodhi SA; Reddy JL; Peram V
Clin Ophthalmol; 2017; 11():1399-1406. PubMed ID: 28848322
[TBL] [Abstract][Full Text] [Related]
18. Retinal Toxicity after Initial Administration of Nivolumab and Ipilimumab.
Kilani A; Vounotrypidis E; König SF; Wolf A
Case Rep Ophthalmol Med; 2023; 2023():9931794. PubMed ID: 38155755
[TBL] [Abstract][Full Text] [Related]
19. Enhanced depth imaging optical coherence tomography features of two types of Vogt-Koyanagi-Harada disease: fuzzy or lost pattern of the choroidal vasculature is of diagnostic value.
Liu X; Wang S; An Y; Zhang H
Front Med (Lausanne); 2024; 11():1339609. PubMed ID: 38721348
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Ipilimumab-induced Multisystem Autoimmune-like Toxicities Suggestive of Vogt-Koyanagi-Harada-like Syndrome.
Monferrer-Adsuara C; Hernández-Bel L; Hernández-Garfella ML; Remolí-Sargues L; Ortiz-Salvador M; Castro-Navarro V; Cervera-Taulet E
Optom Vis Sci; 2021 Nov; 98(11):1309-1316. PubMed ID: 34510146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]